Retatrutide results from clinical trials and user reports, including typical weight loss timelines, side effects, and why it is not yet FDA-approved.
Retatrutide results in clinical trials show dose-dependent weight loss, with participants losing an average of 8.7% to 24.2% of body weight over 48 weeks depending on the dose they received. Retatrutide is an investigational triple-agonist drug, not an FDA-approved medication, so the only verified results come from controlled research rather than products sold online. Individual outcomes vary widely, and anyone considering it should speak with a licensed healthcare professional first.
What the Clinical Trials Show About Retatrutide
Retatrutide (LY3437943) is a once-weekly injection being developed by Eli Lilly. It activates three hormone receptors at once: GIP, GLP-1, and glucagon. That third receptor is what separates it from semaglutide, which targets GLP-1 only, and tirzepatide, which targets GIP and GLP-1.
The most-cited data come from a phase 2 trial published in the New England Journal of Medicine in 2023. Adults with obesity but without diabetes received weekly injections for 48 weeks.
| Weekly dose | Average weight loss at 48 weeks |
|---|---|
| Placebo | 1.6% |
| 1 mg | 8.7% |
| 4 mg | 17.1% |
| 8 mg | 22.8% |
| 12 mg | 24.2% |
Participants with type 2 diabetes lost less weight on average than those without diabetes, a pattern seen across this drug class. Phase 3 TRIUMPH trials are still running or under regulatory review, so no final efficacy or safety profile exists yet.
Retatrutide is not FDA-approved for human use in the United States. Anyone selling it as a finished prescription product is selling something that does not legally exist.
How Long Retatrutide Takes to Work
Appetite changes usually show up before the scale moves. Here is the rough timeline reported in trials and by users:
- Days 1–14: reduced appetite, less food noise, and sometimes nausea.
- Weeks 4–8: early weight loss becomes measurable for most people.
- Weeks 12–24: dose escalation is typically complete and losses accelerate.
- Weeks 24–48: the largest reductions appear; trial results were measured at 48 weeks.
People sharing retatrutide 1 month results often describe a few pounds down plus a sharp drop in cravings, not dramatic fat loss. The two-month mark is usually where a real trend becomes obvious.
What People Report in Reddit and Forum Threads
Searching reddit retatrutide results surfaces hundreds of self-reported logs. They are useful for spotting patterns, but they are not evidence. Nobody verifies the product, the dose, or the scale.
Recurring themes in retatrutide reviews and complaints include:
- Fast, strong appetite suppression, sometimes within 48 hours of the first injection.
- Weight loss that stalls for two or three weeks, then resumes.
- Nausea, fatigue, and heartburn that push people to hold a dose steady.
- Frustration from users who say retatrutide is not working after a month.
A common pattern in retatrutide results before and after posts is a steep early drop followed by slower, steadier losses. Reported retatrutide results in women generally look similar to men's, though starting weight and body composition shift the pace.
When people compare retatrutide peptide results across different forums, the honest conclusion is that anecdotes cluster near the trial averages with plenty of outliers on both ends. A single log tells you very little.
Side Effects, Safety, and "Not Working" Complaints
Gastrointestinal effects are the most common reason people stop. Nausea leads the list, followed by diarrhea, vomiting, and constipation. Most are mild to moderate and ease after a few weeks at a given dose.
Other signals worth knowing:
- Resting heart rate increases of a few beats per minute have been observed.
- Gallbladder problems and pancreatitis are rare but reported across GLP-1 medicines.
- Rapid weight loss can cause muscle loss, hair shedding, and fatigue.
Retatrutide has no established human safety profile outside clinical trials. People with a history of pancreatitis, gallbladder disease, or medullary thyroid cancer in the family should be cautious with this drug class and talk to a clinician first.
When someone says retatrutide is not working, the cause is usually one of four things: the dose is too low, the product is fake or underdosed, the calorie deficit is missing, or expectations are set to trial-level results by week four.
Availability, Storage, and Compounded Versions
Because retatrutide is unapproved, there is no legitimate pharmacy version. Vials sold online are research chemicals or gray-market compounds with no guarantee of purity or sterility.
Handling questions are common in that crowd. A frequent one is how long does retatrutide last after adding bac water — the practical answer for most lyophilized peptides is that a reconstituted vial is typically used within a few weeks while refrigerated, and contamination is a bigger risk than gradual degradation.
Mixing errors are the most dangerous part of gray-market use. A miscalculated dilution can turn a 2 mg dose into 20 mg, which is how people end up in an emergency room with severe vomiting.
How Retatrutide Compares With Other Options
| Option | Mechanism | Status | Typical weight loss |
|---|---|---|---|
| Semaglutide (Wegovy) | GLP-1 | FDA-approved | About 15% at 68 weeks |
| Tirzepatide (Zepbound) | GIP + GLP-1 | FDA-approved | About 21% at 72 weeks |
| Retatrutide | GIP + GLP-1 + glucagon | Investigational | Up to 24% at 48 weeks (phase 2) |
| AOD-9604 | HGH fragment | Not approved for weight loss | Limited, modest evidence |
Questions about aod 9604 vs retatrutide come up often, but the two are not interchangeable. AOD-9604 is a synthetic piece of human growth hormone studied for fat metabolism, while retatrutide is a triple-receptor agonist with far stronger trial data.
Some people ask about using aod 9604 with retatrutide. There is no clinical data on stacking them, and combining unapproved peptides adds risk without proven benefit.
The bottom line: retatrutide's trial results are among the most impressive reported for any obesity drug, but they are not yet available to the public in a regulated form. If you want results you can trust today, FDA-approved options plus a clinician's guidance are the safer path.
Frequently Asked Questions
How much weight can you lose on retatrutide?
In the 48-week phase 2 trial, average weight loss ranged from 8.7% at 1 mg to 24.2% at 12 mg, compared with 1.6% on placebo. People with type 2 diabetes tended to lose somewhat less than those without diabetes. Individual results depend on dose, tolerance, diet, and activity level.
How long does retatrutide take to work?
Most people notice appetite suppression within the first one to two weeks, while measurable weight loss usually appears between weeks four and eight. The largest reductions in trials were measured at 48 weeks, so early results are only a small part of the picture. A stall of two to three weeks is common and does not necessarily mean the drug stopped working.
Are retatrutide Reddit reviews reliable?
Reddit and forum posts are unverified self-reports, so no one confirms the product, dose, or scale readings behind them. They can reveal patterns, such as common side effects or typical timelines, but they cannot substitute for trial data. Treat any single anecdote as one data point rather than proof.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.